PDXK mutations cause polyneuropathy responsive to pyridoxal 5'-phosphate supplementation. (2019)

First Author: Chelban V
Attributed to:  Gene therapy for refractory epilepsy funded by MRC


No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/ana.25524

PubMed Identifier: 31187503

Publication URI: http://europepmc.org/abstract/MED/31187503

Type: Journal Article/Review

Volume: 86

Parent Publication: Annals of neurology

Issue: 2

ISSN: 0364-5134